Cannabis Global Inc (CBGL)
0.0000
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Cannabis Global SG&A Expense (Quarterly): 0.3548M for May 31, 2022
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
May 31, 2022 | 0.3548M |
February 28, 2022 | 0.9382M |
November 30, 2021 | 0.3338M |
August 31, 2021 | 0.5423M |
May 31, 2021 | 0.7069M |
February 28, 2021 | 0.4316M |
November 30, 2020 | 0.4474M |
August 31, 2020 | 1.603M |
May 31, 2020 | 1.239M |
February 29, 2020 | 0.4109M |
November 30, 2019 | 0.3738M |
August 31, 2019 | 0.5246M |
May 31, 2019 | 0.0058M |
February 28, 2019 | 0.0047M |
November 30, 2018 | 0.0148M |
August 31, 2018 | 0.0041M |
May 31, 2018 | 0.0175M |
February 28, 2018 | 0.0052M |
November 30, 2017 | 0.0242M |
August 31, 2017 | 0.0004M |
May 31, 2017 | 0.0004M |
February 28, 2017 | 0.0004M |
November 30, 2016 | 0.0002M |
August 31, 2016 | 0.0004M |
May 31, 2016 | 0.0004M |
Date | Value |
---|---|
February 29, 2016 | 0.0004M |
November 30, 2015 | 0.0004M |
August 31, 2015 | 0.0073M |
May 31, 2015 | 0.0088M |
February 28, 2015 | 0.0111M |
November 30, 2014 | 0.016M |
August 31, 2014 | 0.0096M |
May 31, 2014 | 0.0078M |
February 28, 2014 | 0.0103M |
November 30, 2013 | 0.0144M |
August 31, 2013 | 0.0076M |
May 31, 2013 | 0.0082M |
February 28, 2013 | 0.0101M |
November 30, 2012 | 0.0149M |
August 31, 2012 | 0.007M |
May 31, 2012 | 0.0063M |
February 29, 2012 | 0.0115M |
November 30, 2011 | 0.0281M |
August 31, 2011 | 0.0079M |
May 31, 2011 | 0.0078M |
February 28, 2011 | 0.0098M |
November 30, 2010 | 0.0219M |
August 31, 2010 | 0.0143M |
May 31, 2010 | 0.0134M |
February 28, 2010 | 0.0179M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
0.3338M
Minimum
Nov 2021
1.603M
Maximum
Aug 2020
0.6588M
Average
0.486M
Median
SG&A Expense (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 3.346M |
Palatin Technologies Inc | 2.033M |
iBio Inc | 2.722M |
Theriva Biologics Inc | 1.933M |
Oragenics Inc | 1.797M |